Banca Profilo SpA
F:BPA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Banca Profilo SpA
F:BPA
|
IT |
|
CytomX Therapeutics Inc
NASDAQ:CTMX
|
US |
|
Iren SpA
F:TZ8
|
IT |
|
T
|
TherapeuticsMD Inc
F:29T
|
US |
|
N
|
NuCana PLC
SWB:N04A
|
UK |
|
S
|
Splitit Ltd
OTC:STTTF
|
IL |
|
Babylon Holdings Ltd
F:7UK0
|
US |
|
First Bancshares Inc (Mississippi)
F:3RY
|
US |
|
S
|
Sapiens International Corporation NV
F:S3P
|
IL |
|
P
|
Prime Meridian Resources Corp
OTC:PMDRF
|
CA |
|
MVB Financial Corp
F:MV6
|
US |
|
DiaSorin SpA
F:34D
|
IT |
|
A
|
ACMAT Corp
OTC:ACMT
|
US |
|
T
|
Turmalina Metals Corp
F:3RI
|
CA |
|
Frontera Energy Corp
OTC:FECCF
|
CA |
|
D
|
DiaSorin SpA
DUS:34D
|
IT |
|
Minco Silver Corp
F:XYD
|
CA |
Wall St Price Targets
BPA Price Targets Summary
Banca Profilo SpA
According to Wall Street analysts, the average 1-year price target for BPA is 0.3 EUR with a low forecast of 0.3 EUR and a high forecast of 0.31 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BPA's stock price target?
Price Target
0.3
EUR
According to Wall Street analysts, the average 1-year price target for BPA is 0.3 EUR with a low forecast of 0.3 EUR and a high forecast of 0.31 EUR.
What is the Revenue forecast for Banca Profilo SpA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 5%.
What is the Net Income forecast for Banca Profilo SpA?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 3 years is 22%.
